• Phosphatase Inhibitor Cocktail 2 for SIRT6 Studies

  2026-09-23

  Preserve labile phospho-signals while investigating how SIRT6 loss reshapes translation, nucleolar function, and proteostasis. This workflow-focused guide shows where a broad-spectrum inhibitor belongs in lysate-based assays—and where it cannot replace rapid fixation or protease control.

• HyperScribe T7 Cy3 RNA Labeling Kit Guide

  2026-09-23

  The HyperScribe T7 High Yield Cy3 RNA Labeling Kit is a 25-reaction system for in vitro transcription of randomly Cy3-modified RNA probes. Its tunable Cy3-UTP:UTP balance supports fluorescent probes for in situ hybridization and Northern blot workflows, while the cited sepsis study supplies biological context rather than direct validation of this product.

• Meropenem trihydrate: Mechanism & Research

  2026-09-22

  Meropenem trihydrate is a broad-spectrum carbapenem antibiotic used to investigate bacterial cell-wall inhibition, susceptibility phenotypes, and resistance biology. Product specifications and recent LC-MS/MS metabolomics evidence support controlled use in antibiotic resistance studies, while experimental disease-model applications require separate validation.

• Phenytoin and the Logic of Myelin Remodeling

  2026-09-22

  A translational framework for using Phenytoin to test how activity-dependent sodium channel signaling may influence early, reversible myelin damage—while separating evidence from hypothesis.

• HAX1 Links SARS-CoV-2 Spike to the UPR

  2026-09-21

  The reference study identifies HAX1 as a host factor that binds the SARS-CoV-2 spike S1 subunit and selectively mediates spike-triggered unfolded protein response signaling. Its findings distinguish this response from generic ER stress and show that HAX1 loss worsens spike-associated oxidative and mitochondrial dysfunction, providing a mechanistic framework for host-cell stress studies.

• TMRE mitochondrial membrane potential assay kit Workflow

  2026-09-21

  Translate mitochondrial depolarization into an actionable readout for apoptosis, sodium-overload necrosis, and isolated-organelle studies. This workflow combines TMRE fluorescence with CCCP validation, time-course design, and troubleshooting controls for scalable mitochondrial function analysis.

• Meropenem trihydrate for Resistance Research

  2026-09-20

  Meropenem trihydrate supports controlled antibacterial assays, resistance phenotyping, and metabolomics workflows that distinguish drug susceptibility from carbapenemase-associated biology. This guide connects practical preparation and troubleshooting with a 2025 LC-MS/MS study that identified high-performing metabolic signatures in resistant Enterobacterales.

• Lipid Peroxidation (MDA) Assay Kit for Ferroptosis

  2026-09-19

  Connect malondialdehyde measurement with ferroptosis, doxorubicin-induced liver injury, and oxidative stress studies using matched colorimetric and fluorescence readouts. This workflow explains how to preserve sample integrity, build a defensible calibration curve, and troubleshoot matrix-dependent variability.

• TMRE mitochondrial membrane potential assay kit Workflow

  2026-09-18

  Translate mitochondrial depolarization into a quantitative red-fluorescence readout across apoptosis, sodium-overload, and bioenergetics models. This practical guide combines high-throughput planning, CCCP validation, normalization strategies, and troubleshooting for reliable ΔΨm measurements.

• Polybrene: From Gene Delivery to Metabolic Rigor

  2026-09-18

  Polybrene (Hexadimethrine Bromide) is more than a viral transduction additive: it is a controllable variable at the interface between delivery, cell state, and translational reproducibility. This article connects its established delivery mechanism with new mechanistic insights into mitochondrial proteostasis and OGDH regulation, while defining the controls needed to prevent overinterpretation.

• Necrostatin-1: RIP1 Kinase Inhibitor Guide

  2026-09-17

  Necrostatin-1 is a selective RIP1 kinase inhibitor used to interrogate necroptosis signaling. Its reported potency, solubility, storage, and experimental applications support controlled necroptosis assays, while its effects should not be conflated with ferroptosis biology.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-17

  Shapira-Netanelov and colleagues developed a patient-derived gastric cancer assembloid model that combines matched tumor organoids with tumor-derived stromal subpopulations. The system altered gene expression and drug sensitivity relative to organoid monocultures, providing a more informative framework for tumor–stroma interaction studies, resistance analysis, and personalized preclinical testing.

• PP 3: Src Kinase Control Compound Guide

  2026-09-16

  PP 3 is the 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine research use only chemical designated as a negative control for the Src kinase inhibitor PP 2. Its defined identity, DMSO solubility, 98.00% purity, and −20 °C storage specification support controlled kinase and cell-signaling experiments.

• Deep Learning for iPSC-CM Cardiotoxicity Screening

  2026-09-16

  Grafton and colleagues developed a high-content imaging workflow that combines induced pluripotent stem cell-derived cardiomyocytes with deep learning to detect phenotypic patterns associated with cardiotoxicity. The approach identified liabilities across established bioactive compounds and molecules with unknown targets, illustrating how image-based phenotypic screening can support earlier safety decisions.

• AT-406: From IAP Biology to Translation

  2026-09-15

  AT-406 (SM-406) offers a mechanistically resolved way to study how multi-IAP antagonism can convert apoptotic signaling into measurable cancer-cell death and chemotherapy sensitization. This thought-leadership guide connects target engagement, assay design, xenograft evidence, and translational decision-making without overstating preclinical results.

8532 records 1/569 page Next 12345 下5页 Last page